-transparent.png){kind=logo}
1. Clarithromycin (TE-031, A-56268) was given orally to 46 children with respiratory infections, skin infections and others. A total of 9 patients were excluded; 8 patients refused to take the drug because of it's taste, and 1 patient was later found to have viral pneumonia. Clinical efficacy was therefore evaluated in remaining 37 cases and was good or excellent in 27 cases. 2. Bacteriologically, Haemophilus influenzae strains isolated from 4 patients were eradicated in 1 and decreased in 3, respectively. Haemophilus parainfluenzae and Staphylococcus aureus isolated from 1 patient each were both eradicated. 3. Side effect or abnormal laboratory test values were not observed. 4. Based on the above findings, it appears that TE-031 is a safe and is useful antibiotic for the treatment of mild and moderate respiratory infections. It is necessary, however, to improve the taste of the current granule preparation in order to make the drug more easily palatable to children.
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
February 1989,
The Japanese journal of antibiotics,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
October 1990,
Seikagaku. The Journal of Japanese Biochemical Society,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
May 1990,
Pathologie-biologie,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
May 1989,
Antimicrobial agents and chemotherapy,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
July 1993,
Geburtshilfe und Frauenheilkunde,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
February 1992,
Clinical pharmacy,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
March 1992,
Annals of internal medicine,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
September 1992,
American family physician,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
February 2015,
Chemosphere,
K Hattori, and
H Higashino, and
A Takebe, and
Y Sato, and
M Takedatsu, and
U Nobori, and
M Uh, and
H Tanaka, and
Y Adachi, and
Y Kobayashi
December 1962,
Arzneimittel-Forschung,
